Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay.
Market Analysis and Insights: Global Biological Multiplex Assays Market
The global Biological Multiplex Assays market size is projected to reach US$ 86 million by 2028, from US$ 65 million in 2021, at a CAGR of 3.7% during 2022-2028.
By geography, North America is expected to account for the largest share of the multiplex assays market in 2018, followed by Europe.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biological Multiplex Assays market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biological Multiplex Assays market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biological Multiplex Assays market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biological Multiplex Assays market.
Global Biological Multiplex Assays Scope and Market Size
Biological Multiplex Assays market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Biological Multiplex Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- Protein Assays
- Nucleic Acid Assays
Segment by Application
- Research And Development
- Clinical Diagnosis
By Company
- Luminex
- Thermo Fisher Scientific
- Illumina
- Bio-Rad Laboratories
- Qiagen
- Abcam
- Becton Dickinson
- Merck
- Agilent Technologies
- Meso Scale Diagnostics
- Randox Laboratories
- Quanterix
- Bio-Techne
- Olink
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Biological Multiplex Assays Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Protein Assays
- 1.2.3 Nucleic Acid Assays
- 1.3 Market by Application
- 1.3.1 Global Biological Multiplex Assays Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Research And Development
- 1.3.3 Clinical Diagnosis
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Biological Multiplex Assays Market Perspective (2017-2028)
- 2.2 Biological Multiplex Assays Growth Trends by Region
- 2.2.1 Biological Multiplex Assays Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Biological Multiplex Assays Historic Market Size by Region (2017-2022)
- 2.2.3 Biological Multiplex Assays Forecasted Market Size by Region (2023-2028)
- 2.3 Biological Multiplex Assays Market Dynamics
- 2.3.1 Biological Multiplex Assays Industry Trends
- 2.3.2 Biological Multiplex Assays Market Drivers
- 2.3.3 Biological Multiplex Assays Market Challenges
- 2.3.4 Biological Multiplex Assays Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Biological Multiplex Assays Players by Revenue
- 3.1.1 Global Top Biological Multiplex Assays Players by Revenue (2017-2022)
- 3.1.2 Global Biological Multiplex Assays Revenue Market Share by Players (2017-2022)
- 3.2 Global Biological Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Biological Multiplex Assays Revenue
- 3.4 Global Biological Multiplex Assays Market Concentration Ratio
- 3.4.1 Global Biological Multiplex Assays Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Biological Multiplex Assays Revenue in 2021
- 3.5 Biological Multiplex Assays Key Players Head office and Area Served
- 3.6 Key Players Biological Multiplex Assays Product Solution and Service
- 3.7 Date of Enter into Biological Multiplex Assays Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Biological Multiplex Assays Breakdown Data by Type
- 4.1 Global Biological Multiplex Assays Historic Market Size by Type (2017-2022)
- 4.2 Global Biological Multiplex Assays Forecasted Market Size by Type (2023-2028)
5 Biological Multiplex Assays Breakdown Data by Application
- 5.1 Global Biological Multiplex Assays Historic Market Size by Application (2017-2022)
- 5.2 Global Biological Multiplex Assays Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Biological Multiplex Assays Market Size (2017-2028)
- 6.2 North America Biological Multiplex Assays Market Size by Type
- 6.2.1 North America Biological Multiplex Assays Market Size by Type (2017-2022)
- 6.2.2 North America Biological Multiplex Assays Market Size by Type (2023-2028)
- 6.2.3 North America Biological Multiplex Assays Market Share by Type (2017-2028)
- 6.3 North America Biological Multiplex Assays Market Size by Application
- 6.3.1 North America Biological Multiplex Assays Market Size by Application (2017-2022)
- 6.3.2 North America Biological Multiplex Assays Market Size by Application (2023-2028)
- 6.3.3 North America Biological Multiplex Assays Market Share by Application (2017-2028)
- 6.4 North America Biological Multiplex Assays Market Size by Country
- 6.4.1 North America Biological Multiplex Assays Market Size by Country (2017-2022)
- 6.4.2 North America Biological Multiplex Assays Market Size by Country (2023-2028)
- 6.4.3 U.S.
- 6.4.4 Canada
7 Europe
- 7.1 Europe Biological Multiplex Assays Market Size (2017-2028)
- 7.2 Europe Biological Multiplex Assays Market Size by Type
- 7.2.1 Europe Biological Multiplex Assays Market Size by Type (2017-2022)
- 7.2.2 Europe Biological Multiplex Assays Market Size by Type (2023-2028)
- 7.2.3 Europe Biological Multiplex Assays Market Share by Type (2017-2028)
- 7.3 Europe Biological Multiplex Assays Market Size by Application
- 7.3.1 Europe Biological Multiplex Assays Market Size by Application (2017-2022)
- 7.3.2 Europe Biological Multiplex Assays Market Size by Application (2023-2028)
- 7.3.3 Europe Biological Multiplex Assays Market Share by Application (2017-2028)
- 7.4 Europe Biological Multiplex Assays Market Size by Country
- 7.4.1 Europe Biological Multiplex Assays Market Size by Country (2017-2022)
- 7.4.2 Europe Biological Multiplex Assays Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Biological Multiplex Assays Market Size (2017-2028)
- 8.2 Asia-Pacific Biological Multiplex Assays Market Size by Type
- 8.2.1 Asia-Pacific Biological Multiplex Assays Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Biological Multiplex Assays Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Biological Multiplex Assays Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Biological Multiplex Assays Market Size by Application
- 8.3.1 Asia-Pacific Biological Multiplex Assays Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Biological Multiplex Assays Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Biological Multiplex Assays Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Biological Multiplex Assays Market Size by Region
- 8.4.1 Asia-Pacific Biological Multiplex Assays Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Biological Multiplex Assays Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Biological Multiplex Assays Market Size (2017-2028)
- 9.2 Latin America Biological Multiplex Assays Market Size by Type
- 9.2.1 Latin America Biological Multiplex Assays Market Size by Type (2017-2022)
- 9.2.2 Latin America Biological Multiplex Assays Market Size by Type (2023-2028)
- 9.2.3 Latin America Biological Multiplex Assays Market Share by Type (2017-2028)
- 9.3 Latin America Biological Multiplex Assays Market Size by Application
- 9.3.1 Latin America Biological Multiplex Assays Market Size by Application (2017-2022)
- 9.3.2 Latin America Biological Multiplex Assays Market Size by Application (2023-2028)
- 9.3.3 Latin America Biological Multiplex Assays Market Share by Application (2017-2028)
- 9.4 Latin America Biological Multiplex Assays Market Size by Country
- 9.4.1 Latin America Biological Multiplex Assays Market Size by Country (2017-2022)
- 9.4.2 Latin America Biological Multiplex Assays Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Biological Multiplex Assays Market Size (2017-2028)
- 10.2 Middle East & Africa Biological Multiplex Assays Market Size by Type
- 10.2.1 Middle East & Africa Biological Multiplex Assays Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Biological Multiplex Assays Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Biological Multiplex Assays Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Biological Multiplex Assays Market Size by Application
- 10.3.1 Middle East & Africa Biological Multiplex Assays Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Biological Multiplex Assays Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Biological Multiplex Assays Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Biological Multiplex Assays Market Size by Country
- 10.4.1 Middle East & Africa Biological Multiplex Assays Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Biological Multiplex Assays Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Luminex
- 11.1.1 Luminex Company Details
- 11.1.2 Luminex Business Overview
- 11.1.3 Luminex Biological Multiplex Assays Introduction
- 11.1.4 Luminex Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.1.5 Luminex Recent Developments
- 11.2 Thermo Fisher Scientific
- 11.2.1 Thermo Fisher Scientific Company Details
- 11.2.2 Thermo Fisher Scientific Business Overview
- 11.2.3 Thermo Fisher Scientific Biological Multiplex Assays Introduction
- 11.2.4 Thermo Fisher Scientific Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.2.5 Thermo Fisher Scientific Recent Developments
- 11.3 Illumina
- 11.3.1 Illumina Company Details
- 11.3.2 Illumina Business Overview
- 11.3.3 Illumina Biological Multiplex Assays Introduction
- 11.3.4 Illumina Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.3.5 Illumina Recent Developments
- 11.4 Bio-Rad Laboratories
- 11.4.1 Bio-Rad Laboratories Company Details
- 11.4.2 Bio-Rad Laboratories Business Overview
- 11.4.3 Bio-Rad Laboratories Biological Multiplex Assays Introduction
- 11.4.4 Bio-Rad Laboratories Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.4.5 Bio-Rad Laboratories Recent Developments
- 11.5 Qiagen
- 11.5.1 Qiagen Company Details
- 11.5.2 Qiagen Business Overview
- 11.5.3 Qiagen Biological Multiplex Assays Introduction
- 11.5.4 Qiagen Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.5.5 Qiagen Recent Developments
- 11.6 Abcam
- 11.6.1 Abcam Company Details
- 11.6.2 Abcam Business Overview
- 11.6.3 Abcam Biological Multiplex Assays Introduction
- 11.6.4 Abcam Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.6.5 Abcam Recent Developments
- 11.7 Becton Dickinson
- 11.7.1 Becton Dickinson Company Details
- 11.7.2 Becton Dickinson Business Overview
- 11.7.3 Becton Dickinson Biological Multiplex Assays Introduction
- 11.7.4 Becton Dickinson Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.7.5 Becton Dickinson Recent Developments
- 11.8 Merck
- 11.8.1 Merck Company Details
- 11.8.2 Merck Business Overview
- 11.8.3 Merck Biological Multiplex Assays Introduction
- 11.8.4 Merck Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.8.5 Merck Recent Developments
- 11.9 Agilent Technologies
- 11.9.1 Agilent Technologies Company Details
- 11.9.2 Agilent Technologies Business Overview
- 11.9.3 Agilent Technologies Biological Multiplex Assays Introduction
- 11.9.4 Agilent Technologies Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.9.5 Agilent Technologies Recent Developments
- 11.10 Meso Scale Diagnostics
- 11.10.1 Meso Scale Diagnostics Company Details
- 11.10.2 Meso Scale Diagnostics Business Overview
- 11.10.3 Meso Scale Diagnostics Biological Multiplex Assays Introduction
- 11.10.4 Meso Scale Diagnostics Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.10.5 Meso Scale Diagnostics Recent Developments
- 11.11 Randox Laboratories
- 11.11.1 Randox Laboratories Company Details
- 11.11.2 Randox Laboratories Business Overview
- 11.11.3 Randox Laboratories Biological Multiplex Assays Introduction
- 11.11.4 Randox Laboratories Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.11.5 Randox Laboratories Recent Developments
- 11.12 Quanterix
- 11.12.1 Quanterix Company Details
- 11.12.2 Quanterix Business Overview
- 11.12.3 Quanterix Biological Multiplex Assays Introduction
- 11.12.4 Quanterix Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.12.5 Quanterix Recent Developments
- 11.13 Bio-Techne
- 11.13.1 Bio-Techne Company Details
- 11.13.2 Bio-Techne Business Overview
- 11.13.3 Bio-Techne Biological Multiplex Assays Introduction
- 11.13.4 Bio-Techne Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.13.5 Bio-Techne Recent Developments
- 11.14 Olink
- 11.14.1 Olink Company Details
- 11.14.2 Olink Business Overview
- 11.14.3 Olink Biological Multiplex Assays Introduction
- 11.14.4 Olink Revenue in Biological Multiplex Assays Business (2017-2022)
- 11.14.5 Olink Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer